Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 8 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Sol-Gel Technologies Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 13 | −3 |
| Shares | 5.79M | 61 | 5.80M | +12.3K (+0.2%) |
| Value | $23.7M | $250 | $29.5M | +$5.75M (+24.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MYDA Advisors LLC | 70,400 | $353.0K | 0.20% |
Sold out (4)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 16,715 | $69.0K |
| Corton Capital Inc. | 11,939 | $49.0K |
| Invesco Ltd. | 10,272 | $42.0K |
| Simplex Trading, LLC | 214 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 61 | $250 |